Relief Therapeutics' AGM in Geneva approved 2023 annual report and financial statements; did not grant discharge to board and executive committee.
Relief Therapeutics Holding SA, a biopharmaceutical company focused on specialty, unmet, and rare diseases, announced its annual general meeting (AGM) results in Geneva. Most resolutions were approved, including the 2023 annual report and financial statements, as well as carrying forward the loss for the financial year. However, the AGM did not grant discharge to the board of directors and executive committee for the financial year 2023.
June 27, 2024
6 Articles